RESUMEN

Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cannabis-related disorders is introduced.

Asunto(s)

Abuso de Marihuana/terapia , Cannabis/toxicidad , Interacciones Farmacológicas , Medicina Basada en la Evidencia , Humanos , Abuso de Marihuana/clasificación , Abuso de Marihuana/diagnóstico , Trastornos Mentales/complicaciones , Trastornos Mentales/psicología , Psicosis Inducidas por Sustancias/psicología , Recurrencia